Amundi
SWTX

Amundi’s SpringWorks Therapeutics SWTX Stock Holding History

Amundi’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,772
Closed -$115K – 2074
2023
Q4 		$115K Hold
2,772
– – ﹤0.01% 1747
2023
Q3 		$62.9K Hold
2,772
– – ﹤0.01% 1837
2023
Q2 		$73K Hold
2,772
– – ﹤0.01% 1840
2023
Q1 		$68.6K Sell
2,772
-906
-25% -$26.5K ﹤0.01% 1823
2022
Q4 		$102K Buy
3,678
+1,000
+37% +$24.6K ﹤0.01% 1603
2022
Q3 		$75K Hold
2,678
– – ﹤0.01% 1604
2022
Q2 		$77K Buy
+2,678
New +$97.9K ﹤0.01% 1494

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return